As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
AABB to Present New CGT Standards at Meeting on the Mesa
September 16, 2025
AABB Celebrates Apheresis Awareness Day, Releases New Apheresis Publication
September 16, 2025
FDA to Host Virtual Town Hall on Gene Therapy Manufacturing
September 11, 2025